Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Key Market Size Shifts in the Pruritus Therapeutics Market: A Historical Perspective and beyond
There has been significant growth in the pruritus therapeutics market in the last few years. The market was valued at $11.89 billion in 2024 and is projected to reach $12.51 billion in 2025, growing at a CAGR of 5.3%.
The growth seen in the historical timeline is due to factors such as an increase in the occurrence of pruritus, diverse causes and health conditions, an expanding elderly population, and a heightened emphasis on the quality of life of the patient.
Strong expansion is anticipated in the pruritus therapeutics market size over the coming years. It is projected to reach $16.05 billion by 2029 with a compound annual growth rate (CAGR) of 6.4%.
The projected rise during this period is due to the growing understanding of pruritus pathophysiology, advancements in drug innovations and delivery, focus on individualised healthcare, increase in dermatological research and development, rising awareness and diagnosis rates, and an enhanced interest in plant-based and herbal remedies. Noteworthy trends projected during this period include the creation of itch-specific receptor agonists and antagonists, a shift of market focus towards personalised therapeutic methods, the incorporation of technology in itch tracking and management, and partnerships promoting cross-disciplinary research.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What’s Driving the Continued Growth of the Global Pruritus Therapeutics Market?
The surge in the occurrence of dermatological diseases is predicted to fuel the pruritus therapeutics market’s advancement. These disorders, which include skin, hair, nail, and mucous membrane conditions such as acne, eczema, skin cancer, and fungal infections, frequently dictate the application of pruritus treatments.
The treatment of this itchiness often involves the use of topical treatments, emollients and moisturizers, immunosuppressant drugs, and pruritus medications.
For example, the American Cancer Society, a US-based non-profit dedicated to cancer eradication, forecasts that there will be 108,270 instances of skin cancer in January 2024, which is a 3.2% jump from the 104,930 cases reported in 2023.
Thus, the increasing prevalence of dermatological diseases is contributing to the expansion of the pruritus therapeutics market.
Top Revenue-Generating Segments in the Pruritus Therapeutics Market
The pruritus therapeutics market covered in this report is segmented –
1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
4) By End-User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics
4) By Counterirritants: Menthol-Based Products, Camphor-Based Products
5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream
7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Trends Will Guide the Development Path of the Pruritus Therapeutics Industry?
Key players in the pruritus therapeutics market are concentrating their efforts on creating tailor-made treatments specifically for rare conditions and distinct patient groups. This includes the development of non-systemic ileal bile acid transport inhibitors, a kind of drug that inhibits bile acid absorption in the intestines without greatly impacting the systemic circulation, thereby mitigating potential side effects.
For instance, in June 2023, the France-based pharmaceutical corporation, Ipsen, obtained approval from the Food and Drug Administration (FDA), the U.S. federal health agency, for its medication Bylvay (odevixibat).
This drug is used for the treatment of cholestatic pruritus in Alagille syndrome (ALGS) patients who are 12 months of age or older. Bylvay, an IBATi taken once daily, offers minimal systemic exposure and is the first pharmaceutical product given the green light in the U.S for cholestatic pruritus due to progressive familial intrahepatic cholestasis (PFIC).
It was initially approved for PFIC treatment in Europe and is now accessible by prescription for qualifying ALGS patients.
How Are Different Regions Contributing to the Pruritus Therapeutics Market’s Growth?
North America was the largest region in the pruritus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Firms Are Setting the Benchmark in the Global Pruritus Therapeutics Market?
Major companies operating in the pruritus therapeutics market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co.
Ltd.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=11907
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
